This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2017 Feb;72(2):622-624.

doi: 10.1093/jac/dkw451. Epub 2016 Nov 17.

Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci

Debora Sweeney¹, Audrey Stoneburner¹, Dean L Shinabarger¹, Francis F Arhin², Adam Belley², Greg Moeck², Chris M Pillar³

Affiliations

Affiliations

¹ Micromyx, LLC, Kalamazoo, MI, USA.
² The Medicines Company, Ville Saint Laurent, Québec, Canada.
³ Micromyx, LLC, Kalamazoo, MI, USA cpillar@micromyx.com.

PMID: 27856721
DOI: 10.1093/jac/dkw451

Comparative Study

Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci

Debora Sweeney et al. J Antimicrob Chemother. 2017 Feb.

. 2017 Feb;72(2):622-624.

doi: 10.1093/jac/dkw451. Epub 2016 Nov 17.

Authors

Debora Sweeney¹, Audrey Stoneburner¹, Dean L Shinabarger¹, Francis F Arhin², Adam Belley², Greg Moeck², Chris M Pillar³

Affiliations

¹ Micromyx, LLC, Kalamazoo, MI, USA.
² The Medicines Company, Ville Saint Laurent, Québec, Canada.
³ Micromyx, LLC, Kalamazoo, MI, USA cpillar@micromyx.com.

PMID: 27856721
DOI: 10.1093/jac/dkw451

No abstract available

PubMed Disclaimer

Similar articles

Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T Jr, Moeck G. McKay GA, et al. J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15. J Antimicrob Chemother. 2009. PMID: 19369269
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
Biedenbach DJ, Arhin FF, Moeck G, Lynch TF, Sahm DF. Biedenbach DJ, et al. Int J Antimicrob Agents. 2015 Dec;46(6):674-81. doi: 10.1016/j.ijantimicag.2015.08.014. Epub 2015 Oct 20. Int J Antimicrob Agents. 2015. PMID: 26541881
In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
Arhin FF, Seguin DL, Belley A, Moeck G. Arhin FF, et al. Diagn Microbiol Infect Dis. 2017 Oct;89(2):168-171. doi: 10.1016/j.diagmicrobio.2017.06.023. Epub 2017 Jul 1. Diagn Microbiol Infect Dis. 2017. PMID: 28733126
Vancomycin-resistant enterococci.
Rubinstein E, Keynan Y. Rubinstein E, et al. Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006. Crit Care Clin. 2013. PMID: 24094380 Review.
[Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Klare I, Witte W. Klare I, et al. Wien Klin Wochenschr. 1997 May 9;109(9):293-300. Wien Klin Wochenschr. 1997. PMID: 9265387 Review. German. No abstract available.

See all similar articles

Cited by

Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges.
Radford-Smith DE, Anthony DC. Radford-Smith DE, et al. Antibiotics (Basel). 2025 May 19;14(5):522. doi: 10.3390/antibiotics14050522. Antibiotics (Basel). 2025. PMID: 40426588 Free PMC article. Review.
Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.
Stojković D, Petrović J, Carević T, Soković M, Liaras K. Stojković D, et al. Antibiotics (Basel). 2023 May 25;12(6):963. doi: 10.3390/antibiotics12060963. Antibiotics (Basel). 2023. PMID: 37370282 Free PMC article. Review.
Is an oritavancin catheter lock solution active against biofilms of staphylococci and enterococci?
Díaz-Navarro M, Cercenado E, Monte A, Visedo A, Rodríguez C, Pérez-Granda MJ, Muñoz P, Guembe M. Díaz-Navarro M, et al. Heliyon. 2025 Jan 10;11(2):e41885. doi: 10.1016/j.heliyon.2025.e41885. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39877599 Free PMC article.
New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.
Tran TT, Gomez Villegas S, Aitken SL, Butler-Wu SM, Soriano A, Werth BJ, Munita JM. Tran TT, et al. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0261420. doi: 10.1128/aac.02614-20. Epub 2022 Apr 27. Antimicrob Agents Chemother. 2022. PMID: 35475634 Free PMC article. Review.
N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.
Szűcs Z, Bereczki I, Rőth E, Milánkovits M, Ostorházi E, Batta G, Nagy L, Dombrádi Z, Borbás A, Herczegh P. Szűcs Z, et al. J Antibiot (Tokyo). 2020 Sep;73(9):603-614. doi: 10.1038/s41429-020-0313-6. Epub 2020 May 15. J Antibiot (Tokyo). 2020. PMID: 32409678

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information